Related Experiment Video
Updated: May 29, 2026

08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Enhanced Hyperthermia Induced by MDMA in Parkin Knockout Mice
Y Takamatsu1, H Shiotsuki, S Kasai
1Division of Psychobiology, Tokyo Institute of Psychiatry, 2-1-8 Kamikitazawa, Setagaya-ku, Tokyo 156-8585, Japan.
Current Neuropharmacology
|September 3, 2011
Summary
Parkin protein protects against MDMA neurotoxicity. Parkin knockout mice showed increased hyperthermia after MDMA exposure, indicating parkin’s protective role in dopamine neuron damage.
Area of Science:
- Neuroscience
- Toxicology
- Genetics
Background:
- 3,4-methylenedioxymethamphetamine (MDMA) causes severe toxicity to dopamine (DA) and serotonin neurons.
- MDMA selectively destroys DA neurons in the nigrostriatal pathway, a hallmark of Parkinson's disease (PD).
- Parkin gene mutations are linked to autosomal recessive parkinsonism, and parkin is thought to protect against neurotoxic insults.
Purpose of the Study:
- To investigate the role of parkin in MDMA-induced hyperthermia, a factor contributing to neuronal damage.
- To clarify parkin's protective function against MDMA neurotoxicity using parkin knockout mice.
Main Methods:
- Parkin knockout mice (heterozygous and homozygous) and wildtype mice were used.
- Mice were injected intraperitoneally with MDMA (30 mg/kg) at a controlled ambient temperature (22 ± 2°C).
- Rectal body temperature was measured at baseline and at 15, 30, 45, and 60 minutes post-injection.
Main Results:
- Parkin knockout mice exhibited significantly enhanced hyperthermia following MDMA administration compared to wildtype mice.
- This suggests that the absence of functional parkin exacerbates MDMA-induced temperature elevation.
- The findings indicate a correlation between parkin deficiency and increased susceptibility to MDMA's hyperthermic effects.
Conclusions:
- Parkin plays a significant protective role in mitigating MDMA-induced hyperthermia.
- The study supports the hypothesis that parkin confers neuroprotection against MDMA toxicity.
- These findings have implications for understanding the genetic factors influencing susceptibility to neurotoxic drug effects and potentially Parkinson's disease pathogenesis.

